AXIN1 and non-small cell lung carcinoma: Ophiopogonin B was found to have the ability to enhance the interaction between AXIN and β-catenin and reduce β-catenin protein translocation to inhibit the WNT/β-catenin signaling pathway, which reduces the migration and invasion of non-small cell lung cancer (NSCLC) cells [126].